Hospital groups file lawsuit to block price transparency rule

A group of prominent hospital associations have filed a lawsuit against HHS to stop the implementation of a rule that requires hospitals to post their prices for services online and update it regularly.

The four hospital groups––the American Hospital Association (AHA), the Association of American Medical Colleges (AAMC), the Children’s Hospital Association (CHA) and the Federation of American Hospitals (FAH)––previously announced their plan to sue the agency when the rule was finalized in November. They officially filed suit on Dec. 4.

The rule, which takes effect Jan. 2021, requires all hospitals, not just those that provide Medicare or Medicaid services, to publish their prices, including prices for services negotiated with specific health insurers. The goal of the rule is to help consumers make better choices about their healthcare and give them a better idea of how much they can expect to pay for a hospital visit or specific service.

However, the rule is not without costs to providers. CMS anticipates implementing the rule will cost individual hospitals 150 hours and $12,000 in the first year alone. Collectively, across more than 6,000 hospitals, the cost will total 900,3000 hours and $71.4 million.

The lawsuit specifically takes aim at the part of the rule that requires hospitals to publish their negotiated rates with health insurers, with the hospital groups arguing HHS lacks the authority to require and enforce this provision. They also argued the requirement violates the first amendment and will confuse patients.

“America’s hospitals and health systems stand with patients and are dedicated to ensuring they have the information needed to make informed health care decisions, including what their expected out-of-pocket costs will be,” Rick Pollack, president and CEO of the AHA, said in a statement. “Instead of giving patients relevant information about costs, this rule will lead to widespread confusion and even more consolidation in the commercial health insurance industry. We stand ready to work with CMS and other stakeholders to advance real solutions for patients.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.